IP Library Assignment 021932/0001
Patent Assignment
Reel/Frame 021932/0001

Release of Security Interest

Recorded: 2008-12-05 Pages: 35
Assignors
OFCO CLUB IV
Executed: 2008-12-04
HEALTHCAP IV KB
Executed: 2008-12-04
HEALTHCAP IV, L.P.
Executed: 2008-12-04
HEALTHCAP IV BIS, L.P.
Executed: 2008-12-04
S.R. ONE, LIMITED
Executed: 2008-12-04
QUAKER BIOVENTURES, L.P.
Executed: 2008-12-04
POSCO BIOVENTURES I, L.P.
Executed: 2008-12-04
Assignee
NUCLEONICS, INC.
13 SUMMIT SQUARE CENTER #305, LANGHORNE, PENNSYLVANIA, 19047-1098
Covered Properties (28)
Methods and compositions for inhibiting the function of polynucleotide sequence
Application: 10/009,134 →
Use of post-transcriptional gene silencing for identifying nucleic acid sequences that modulate the function of a cell
Application: 10/062,707 →
Publication: US 2002/0132257
Methods and compositions for silencing genes without inducing toxicity
Application: 10/425,006 →
Publication: US 2004/0180438
Methods for delivery of nucleic acids
Application: 10/513,708 →
Publication: US 2006/0084617
Double stranded rna structures and constructs, and methods for generating and using the same
Application: 10/522,962 →
Publication: US 2005/0239728
Double-stranded rna structures and constructs, and methods for generating and using the same
Application: 10/531,349 →
Publication: US 2006/0035344
Methods and constructs for evaluation of rnai targets and effector molecules
Application: 10/547,256 →
Publication: US 2006/0263764
Conserved Hbv and Hcv Sequences Useful for Gene Silencing
Patent: 8,350,021 →
Application: 10/560,377 →
Publication: US 2008/0070854
Post-Transcriptional Gene Silencing Using Expressed Double Stranded Rna
Patent: 9,051,566 →
Application: 10/762,395 →
Publication: US 2004/0152117
Methods and compositions for inhibiting the function of polynucleotide sequences
Application: 10/773,735 →
Publication: US 2004/0138168
Methods and compositions for inhibiting the function of polynucleotide sequences
Application: 10/780,450 →
Publication: US 2004/0147476
Transfection Kinetics and Structural Promoters
Patent: 7,527,945 →
Application: 10/829,747 →
Publication: US 2005/0039224
Methods and compositions for inhibiting the function of polynucleotide sequences
Application: 10/836,856 →
Publication: US 2004/0198690
Methods and compositions for inhibiting the function of polynucleotide sequences
Application: 10/897,361 →
Publication: US 2004/0266721
Methods and compositions for inhibiting the function of polynucleotide sequences
Application: 10/912,438 →
Publication: US 2005/0004067
Methods and compositions for inhibiting the function of polynucleotide sequences
Application: 10/916,043 →
Publication: US 2005/0043267
Methods and compositions for inhibiting the function of polynucleotide sequences
Application: 10/920,965 →
Publication: US 2005/0054603
Methods and compositions for inhibiting the function of polynucleotide sequences
Application: 10/949,845 →
Publication: US 2005/0064496
Methods and compositions for inhibiting the function of polynucleotide sequences
Application: 10/977,537 →
Publication: US 2005/0239202
Methods and compositions for inhibiting the function of polynucleotide sequences
Application: 11/333,672 →
Publication: US 2006/0104956
Methods and compositions for silencing genes without inducing toxicity
Application: 11/542,291 →
Publication: US 2007/0027103
Methods and compositions for inhibiting the function of polynucleotide sequences
Application: 11/606,550 →
Publication: US 2008/0081792
Methods and compositions for inhibiting the function of polynucleotide sequences
Application: 11/606,590 →
Publication: US 2007/0238178
Methods and compositions for inhibiting the function of polynucleotide sequences
Application: 11/638,734 →
Publication: US 2007/0219151
Methods and compositions for inhibiting the function of polynucleotide sequences
Application: 11/638,809 →
Publication: US 2007/0232557
Multiple Rna Polymerase Iii Promoter Expression Constructs
Patent: 7,985,581 →
Application: 11/660,937 →
Publication: US 2009/0298909
Transfection Kinetics and Structural Promoters
Patent: 7,897,382 →
Application: 12/034,541 →
Publication: US 2009/0081654
Methods and Compositions for Inhibiting the Function of Polynucleotide Sequences
Application: 12/106,649 →
Publication: US 2008/0194514
Related Assignments (15)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Oct 22, 2001
From: PACHUK, CATHERINE; SAKISHCHANDRAN, C.
To: AMERICAN HOME PRODUCTS CORPORATION
Reel/Frame 012594/0067 →
Change of Name Apr 12, 2002
From: AMERICAN HOME PRODUCTS CORPORATION
To: WYETH
Reel/Frame 012828/0928 →
Assignment of Assignor's Interest May 22, 2002
From: GIORDANO, TONY; PACHUK, CATHERINE J.; SATISCHANDRAN, C.
To: NUCLEONICS, INC.
Reel/Frame 013545/0719 →
Assignment of Assignor's Interest Oct 22, 2004
From: MESSAGE PHARMACEUTICALS, INC.
To: NUCLEONICS, INC.
Reel/Frame 015284/0682 →
Assignment of Assignor's Interest Nov 4, 2004
From: PACHUK, CATHERINE J.; SATISHCHANDRAN, C.
To: NUCLEONICS, INC.
Reel/Frame 015339/0274 →
Assignment of Assignor's Interest Mar 17, 2005
From: PACHUK, CATHERINE J.
To: NUCLEONICS, INC.
Reel/Frame 015919/0756 →
Assignment of Assignor's Interest Jun 7, 2005
From: SATISHCHANDRAN, C.
To: NUCLEONICS, INC.
Reel/Frame 016306/0894 →
Assignment of Assignor's Interest Jun 8, 2005
From: PACHUK, CATHERINE; SATISHCHANDRAN, C.; MCCALLUS, DANIEL E.
To: NUCLEONICS, INC.
Reel/Frame 016313/0619 →
Assignment of Assignor's Interest Jun 8, 2005
From: PACHUK, CATHERINE; SATISHCHANDRAN, C.; CHOPRA, MANINDER; SHUEY, DAVID
To: NUCLEONICS, INC.
Reel/Frame 016313/0637 →
Assignment of Assignor's Interest Aug 16, 2007
From: PACHUK, CATHERINE J.; SATISHCHANDRAN, CHANDRASEKHAR; ZURAWSKI, VINCENT R.; MINTZ, LIAT
To: NUCLEONICS, INC.
Reel/Frame 019705/0646 →
Assignment of Assignor's Interest Apr 9, 2008
From: WYETH
To: NUCLEONICS, INC.
Reel/Frame 020778/0766 →
Security Agreement Sep 29, 2008
From: NUCLEONICS, INC.
To: NEW ENTERPRISE ASSOCIATES 10, LIMITED PARTNERSHIP; S.R. ONE, LIMITED; OFCO CLUB IV; HEALTHCAP IV KB
Reel/Frame 021602/0423 →
Corrective Assignment to Correct the Serial Number 10/009,234 Previously Recorded on Reel 021602 Frame 0423. Assignor(S) Hereby Confirms the Security Interest Agreement Is Still in Effect. Oct 16, 2008
From: NUCLEONICS, INC.
To: NEW ENTERPRISE ASSOCIATES 10, LIMITED PARTNERSHIP; S.R. ONE, LIMITED; OFCO CLUB IV; HEALTHCAP IV KB
Reel/Frame 021693/0349 →
Assignment of Assignor's Interest Mar 12, 2009
From: NUCLEONICS, INC.
To: ALNYLAM PHARMACEUTICALS, INC.
Reel/Frame 022386/0468 →
Security Interest Oct 1, 2025
From: ALNYLAM PHARMACEUTICALS, INC.; SIRNA THERAPEUTICS, INC.
To: BANK OF AMERICA, N.A.
Reel/Frame 072996/0337 →